TREATMENT OF CANCERS USING ANTI-EMP2 ANTIBODY AND PD-1/PDL-1 PATHWAY ANTAGONIST COMBINATION THERAPY

• 收藏
• 分享

专利权人:

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

发明人:

Madhuri WADEHRA,Jonathan BRAUN,Lynn K. GORDON

申请号：

US16478814

公开号：

US20190352399A1

申请日:

2018.01.22

申请国别(地区):

US

年份:

2019

代理人:

摘要：

Provided herein are compositions and methods for the treatment of a cancer in a subject having such a cancer (e.g., a breast cancer). In particular, the compositions provided herein include an anti-EMP2 antibody and a PD-1/PD-L1 pathway antagonist.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/